業績一覧
ACHIEVEMENT LIST
-
Kimura S, Suzuki M, Honma A, Nakazono A, Osawa M, Nakamaru Y, Homma A: Objective evaluation of caudal deviation of the nasal septum and selection of the appropriate septoplasty technique.
Auris Nasus Larynx. 49:67-76, 2022
-
Hamada S, Kano S, Murai J, Suzuki T, Tsushima N, Mizumachi T, Suzuki M, Takashima T, Taniyama D, Sakamoto N, Fujioka Y, Ohba Y, Homma A: Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy.
Front Oncol. 12: 978875, 2022
-
Fujima N, Shimizu Y, Yoneyama M, Nakagawa J, Kameda H, Harada T, Hamada S, Suzuki T, Tsushima N, Kano S, Homma A, Kudo K：Amide proton transfer imaging for the determination of human papillomavirus status in patients with oropharyngeal squamous cell carcinoma．
Medicine (Baltimore). 101(28): e29457, 2022
-
Fujima N, Shimizu Y, Yoneyama M, Nakagawa J, Kameda H, Harada T, Hamada S, Suzuki T, Tsushima N, Kano S, Homma A, Kudo K：The utility of diffusion-weighted T2 mapping for the prediction of histological tumor grade in patients with head and neck squamous cell carcinoma．
Quant Imaging Med Surg. 12(8): 4024-4032, 2022
-
Hirakawa H, Matsuzuka T, Uemura H, Yoshimoto S, Miura K, Shiotani A, Sugasawa M, Homma A, Yokoyama J, Tsukahara K, Yoshizaki T, Hanai N, Suzuki H, Suzuki M, Hasegawa Y：Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 status．
Auris Nasus Larynx. 49(4): 680-689, 2022
-
Imamura Y, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ota I, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Yokota T, Okano S, Tanaka K, Onoe T, Ariizumi Y, Homma A: Systemic therapy for salivary gland malignancy: current status and future perspectives.
Jpn J Clin Oncol. 52:293-302, 2022
-
Ishii R, Ohkoshi A, Kiyota N, Matsuura K, Yasuda K, Imamura Y, Saito Y, Homma A; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Management of elderly patients with head and neck cancer.
Jpn J Clin Oncol. 52 :313-321, 2022
-
Ishi Y, Yamaguchi S, Hatanaka KC, Takakuwa E, Motegi H, Honda T, Kobayashi H, Terasaka S, Homma A, Fujimura M, Houkin K:
Cystic Intracranial Recurrence of Olfactory Neuroblastoma without Accumulation on Fluorine-18-fluorodeoxyglucose Positron Emission Tomography. Acta Med Okayama. 76 :93-98, 2022
-
Kiyota N, Tahara M, Mizusawa J, Kodaira T, Fujii H, Yamazaki T, Mitani H, Iwae S, Fujimoto Y, Onozawa Y, Hanai N, Ogawa T, Hara H, Monden N, Shimura E, Minami S, Fujii T, Tanaka K, Homma A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Ota I, Shiga K, Sugasawa M, Asakage T, Saito Y, Murono S, Nishimura Y, Nakamura K, Hayashi R; Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG). Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial.
J Clin Oncol. 40 :1980-1990, 2022
-
Bree Rd, Meerkerk CDA, Halmos GB, Mäkitie AA, Homma A, Rodrigo JP, López F, Takes RP, Vermorken JB, Ferlito A：Measurement of Sarcopenia in Head and Neck Cancer Patients and Its Association With Frailty．
Front Oncol. 12: 884988, 2022